Contact Us Youtube Facebook linkedin Twitter

Fact sheets

Biosimilar Medicines

The PBAC recently made a recommendation to allow biologics to be substituted with biosimilar drugs by clinicians and pharmacists if the biosimilar is found to be a safe and effective equivalent treatment.

For further information refer to: Statement from PBAC safety of biosimilars

A biosimilar or similar biological medicinal product (SBMP) is a version of an already registered biological medicine that:

For up to date information of Biosimilar medicines refer to the TGA website

Other sources of information:

Sanofi Position statement on biosimilars

NKF FAQs Biosimilars Booklet


ADEA Fact Sheets